Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis

NCT00847886 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: LX3305
DRUG: LX3305 Placebo
DRUG: Methotrexate

Sponsor

Lexicon Pharmaceuticals